Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,130.00
(
0.48%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
100.55
(
-0.10%
)
Bitcoin
73,765.10
(
-0.24%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Robert C Jonson

Send PM Follow Ignore
Followers 29
Posts 2152
Boards Moderated 0
Alias Born 10/28/2007

Robert C Jonson

Re: ThomasS post# 76241

Monday, 04/20/2009 8:25:55 AM

Monday, April 20, 2009 8:25:55 AM

Post# of 257253
Peregrine Pharmaceuticals Reports Positive Preliminary Data From Phase II Bavituximab Lung Cancer Trial
<a href=http://http://ir.peregrineinc.com/releaseDetail.cfm?ReleaseID=378060
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now